Skip to main content
logo
Ilyang Pharmaceutical Co.,Ltd (KRX:007570)
South Korea flag South Korea · Delayed Price · Currency is KRW
8,430.00
+50.00 (0.60%)
Aug 3, 2026, 3:30 PM KST

KRX:007570 Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
20,1626,9059,032-2,40919,38514,032
Depreciation & Amortization
8,3248,3449,82411,97111,76711,227
Other Amortization
-----14.99
Loss (Gain) From Sale of Assets
-89.57-89.729.54-0.51-21.22-2.86
Asset Writedown & Restructuring Costs
-45-45-2.49-40.5125.51-263.19
Loss (Gain) From Sale of Investments
-280.758-27.43-30.5724.78-
Loss (Gain) on Equity Investments
1,276843.99-2,08313,425-10,754-9,236
Provision & Write-off of Bad Debts
256.59270.6-52.33-393.8-964.921,067
Other Operating Activities
2,9902,5602,4813,6042,42716,825
Change in Accounts Receivable
4,402-325.451,282-1,0873,101-10,261
Change in Inventory
-2,965-7,550-7,606-5,574-16,8305,719
Change in Accounts Payable
-3,662-1,938-3,545-3,4256,5024,160
Change in Other Net Operating Assets
13,1403,057-3,696-1,421-8,77918,147
Operating Cash Flow
43,50812,0415,61514,6195,88351,429
Operating Cash Flow Growth
36780.88%114.44%-61.59%148.49%-88.56%-10.53%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-5,689-5,717-38,200-5,883-3,946-12,371
Sale of Property, Plant & Equipment
26.9726.97-0.52200.92
Sale (Purchase) of Intangibles
-5,334-4,547-2,423-949.74-12.08-2,128
Investment in Securities
3,6573,0023,365-4,60628,115-565.4
Other Investing Activities
10.310.382.53-77.65-14366.7
Investing Cash Flow
-7,329-7,225-37,175-11,51624,163-14,671

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-29,91168,71624,78935,00039,147
Long-Term Debt Issued
-15,3008,7006,000--
Total Debt Issued
40,21145,21177,41630,78935,00039,147
Short-Term Debt Repaid
--26,200-42,000-30,000-56,500-31,147
Long-Term Debt Repaid
--542.1-717.18-2,753-3,737-10,758
Total Debt Repaid
-42,863-26,742-42,717-32,753-60,237-41,905
Net Debt Issued (Repaid)
-2,65118,46934,699-1,965-25,237-2,758
Issuance of Common Stock
--515.48---
Repurchase of Common Stock
-535.18-1,000--2,000-3,000-
Dividends Paid
-3,183-2,881-2,974-2,992-3,942-2,350
Other Financing Activities
23.628.6-0.56-22183.5-31,524
Financing Cash Flow
-6,34614,61732,240-6,978-31,996-36,632

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
63.57-74.22201.72115.33-164.64-
Miscellaneous Cash Flow Adjustments
0-----
Net Cash Flow
29,89719,359881.17-3,759-2,115125.49

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
37,8196,323-32,5858,7361,93839,057
Free Cash Flow Growth
---350.88%-95.04%-17.44%
Free Cash Flow Margin
13.73%2.32%-12.13%3.28%0.78%16.11%
Free Cash Flow Per Share
2160.43352.33-1767.81484.85106.902145.40
Levered Free Cash Flow
10,352203.66-37,22010,211-1,03734,080
Unlevered Free Cash Flow
12,2052,098-35,38812,227295.8635,249

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
4,0264,0403,6343,3122,0961,912
Cash Income Tax Paid
6,3466,7751,5981,2395,1081,320
Change in Working Capital
10,916-6,756-13,566-11,507-16,00617,765